Global Oncology Treatment Drug Market Size, Status and Forecast 2023-2027

Report ID: 888095 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy (Biologic Therapy)
        1.2.5 Hormonal Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Oncology Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncology Treatment Drug Market Perspective (2016-2027)
    2.2 Oncology Treatment Drug Growth Trends by Regions
        2.2.1 Oncology Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncology Treatment Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Oncology Treatment Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Oncology Treatment Drug Industry Dynamic
        2.3.1 Oncology Treatment Drug Market Trends
        2.3.2 Oncology Treatment Drug Market Drivers
        2.3.3 Oncology Treatment Drug Market Challenges
        2.3.4 Oncology Treatment Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncology Treatment Drug Players by Revenue
        3.1.1 Global Top Oncology Treatment Drug Players by Revenue (2016-2021)
        3.1.2 Global Oncology Treatment Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncology Treatment Drug Revenue
    3.4 Global Oncology Treatment Drug Market Concentration Ratio
        3.4.1 Global Oncology Treatment Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Treatment Drug Revenue in 2020
    3.5 Oncology Treatment Drug Key Players Head office and Area Served
    3.6 Key Players Oncology Treatment Drug Product Solution and Service
    3.7 Date of Enter into Oncology Treatment Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Treatment Drug Breakdown Data by Type
    4.1 Global Oncology Treatment Drug Historic Market Size by Type (2016-2021)
    4.2 Global Oncology Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Oncology Treatment Drug Breakdown Data by Application
    5.1 Global Oncology Treatment Drug Historic Market Size by Application (2016-2021)
    5.2 Global Oncology Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncology Treatment Drug Market Size (2016-2027)
    6.2 North America Oncology Treatment Drug Market Size by Type
        6.2.1 North America Oncology Treatment Drug Market Size by Type (2016-2021)
        6.2.2 North America Oncology Treatment Drug Market Size by Type (2022-2027)
        6.2.3 North America Oncology Treatment Drug Market Size by Type (2016-2027)
    6.3 North America Oncology Treatment Drug Market Size by Application
        6.3.1 North America Oncology Treatment Drug Market Size by Application (2016-2021)
        6.3.2 North America Oncology Treatment Drug Market Size by Application (2022-2027)
        6.3.3 North America Oncology Treatment Drug Market Size by Application (2016-2027)
    6.4 North America Oncology Treatment Drug Market Size by Country
        6.4.1 North America Oncology Treatment Drug Market Size by Country (2016-2021)
        6.4.2 North America Oncology Treatment Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncology Treatment Drug Market Size (2016-2027)
    7.2 Europe Oncology Treatment Drug Market Size by Type
        7.2.1 Europe Oncology Treatment Drug Market Size by Type (2016-2021)
        7.2.2 Europe Oncology Treatment Drug Market Size by Type (2022-2027)
        7.2.3 Europe Oncology Treatment Drug Market Size by Type (2016-2027)
    7.3 Europe Oncology Treatment Drug Market Size by Application
        7.3.1 Europe Oncology Treatment Drug Market Size by Application (2016-2021)
        7.3.2 Europe Oncology Treatment Drug Market Size by Application (2022-2027)
        7.3.3 Europe Oncology Treatment Drug Market Size by Application (2016-2027)
    7.4 Europe Oncology Treatment Drug Market Size by Country
        7.4.1 Europe Oncology Treatment Drug Market Size by Country (2016-2021)
        7.4.2 Europe Oncology Treatment Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Treatment Drug Market Size (2016-2027)
    8.2 Asia-Pacific Oncology Treatment Drug Market Size by Type
        8.2.1 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncology Treatment Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncology Treatment Drug Market Size by Application
        8.3.1 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncology Treatment Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncology Treatment Drug Market Size by Region
        8.4.1 Asia-Pacific Oncology Treatment Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncology Treatment Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncology Treatment Drug Market Size (2016-2027)
    9.2 Latin America Oncology Treatment Drug Market Size by Type
        9.2.1 Latin America Oncology Treatment Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Oncology Treatment Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Oncology Treatment Drug Market Size by Type (2016-2027)
    9.3 Latin America Oncology Treatment Drug Market Size by Application
        9.3.1 Latin America Oncology Treatment Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Oncology Treatment Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Oncology Treatment Drug Market Size by Application (2016-2027)
    9.4 Latin America Oncology Treatment Drug Market Size by Country
        9.4.1 Latin America Oncology Treatment Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Oncology Treatment Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Treatment Drug Market Size (2016-2027)
    10.2 Middle East & Africa Oncology Treatment Drug Market Size by Type
        10.2.1 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncology Treatment Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncology Treatment Drug Market Size by Application
        10.3.1 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncology Treatment Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncology Treatment Drug Market Size by Country
        10.4.1 Middle East & Africa Oncology Treatment Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncology Treatment Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Oncology Treatment Drug Introduction
        11.1.4 Roche Revenue in Oncology Treatment Drug Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene Oncology Treatment Drug Introduction
        11.2.4 Celgene Revenue in Oncology Treatment Drug Business (2016-2021)
        11.2.5 Celgene Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Oncology Treatment Drug Introduction
        11.3.4 Novartis Revenue in Oncology Treatment Drug Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Oncology Treatment Drug Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Oncology Treatment Drug Business (2016-2021)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Oncology Treatment Drug Introduction
        11.5.4 Johnson & Johnson Revenue in Oncology Treatment Drug Business (2016-2021)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Merck & Co.
        11.6.1 Merck & Co. Company Details
        11.6.2 Merck & Co. Business Overview
        11.6.3 Merck & Co. Oncology Treatment Drug Introduction
        11.6.4 Merck & Co. Revenue in Oncology Treatment Drug Business (2016-2021)
        11.6.5 Merck & Co. Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Details
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Oncology Treatment Drug Introduction
        11.7.4 AstraZeneca Revenue in Oncology Treatment Drug Business (2016-2021)
        11.7.5 AstraZeneca Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Oncology Treatment Drug Introduction
        11.8.4 Pfizer Revenue in Oncology Treatment Drug Business (2016-2021)
        11.8.5 Pfizer Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Oncology Treatment Drug Introduction
        11.9.4 Amgen Revenue in Oncology Treatment Drug Business (2016-2021)
        11.9.5 Amgen Recent Development
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Oncology Treatment Drug Introduction
        11.10.4 Eli Lilly Revenue in Oncology Treatment Drug Business (2016-2021)
        11.10.5 Eli Lilly Recent Development
    11.11 AbbVie
        11.11.1 AbbVie Company Details
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Oncology Treatment Drug Introduction
        11.11.4 AbbVie Revenue in Oncology Treatment Drug Business (2016-2021)
        11.11.5 AbbVie Recent Development
    11.12 Takeda
        11.12.1 Takeda Company Details
        11.12.2 Takeda Business Overview
        11.12.3 Takeda Oncology Treatment Drug Introduction
        11.12.4 Takeda Revenue in Oncology Treatment Drug Business (2016-2021)
        11.12.5 Takeda Recent Development
    11.13 Astellas
        11.13.1 Astellas Company Details
        11.13.2 Astellas Business Overview
        11.13.3 Astellas Oncology Treatment Drug Introduction
        11.13.4 Astellas Revenue in Oncology Treatment Drug Business (2016-2021)
        11.13.5 Astellas Recent Development
    11.14 Ipsen
        11.14.1 Ipsen Company Details
        11.14.2 Ipsen Business Overview
        11.14.3 Ipsen Oncology Treatment Drug Introduction
        11.14.4 Ipsen Revenue in Oncology Treatment Drug Business (2016-2021)
        11.14.5 Ipsen Recent Development
    11.15 Sanofi
        11.15.1 Sanofi Company Details
        11.15.2 Sanofi Business Overview
        11.15.3 Sanofi Oncology Treatment Drug Introduction
        11.15.4 Sanofi Revenue in Oncology Treatment Drug Business (2016-2021)
        11.15.5 Sanofi Recent Development
    11.16 Bayer
        11.16.1 Bayer Company Details
        11.16.2 Bayer Business Overview
        11.16.3 Bayer Oncology Treatment Drug Introduction
        11.16.4 Bayer Revenue in Oncology Treatment Drug Business (2016-2021)
        11.16.5 Bayer Recent Development
    11.17 Biogen Idec
        11.17.1 Biogen Idec Company Details
        11.17.2 Biogen Idec Business Overview
        11.17.3 Biogen Idec Oncology Treatment Drug Introduction
        11.17.4 Biogen Idec Revenue in Oncology Treatment Drug Business (2016-2021)
        11.17.5 Biogen Idec Recent Development
    11.18 Teva
        11.18.1 Teva Company Details
        11.18.2 Teva Business Overview
        11.18.3 Teva Oncology Treatment Drug Introduction
        11.18.4 Teva Revenue in Oncology Treatment Drug Business (2016-2021)
        11.18.5 Teva Recent Development
    11.18 Otsuka
        .1 Otsuka Company Details
        .2 Otsuka Business Overview
        .3 Otsuka Oncology Treatment Drug Introduction
        .4 Otsuka Revenue in Oncology Treatment Drug Business (2016-2021)
        .5 Otsuka Recent Development
    11.20 Eisai
        11.20.1 Eisai Company Details
        11.20.2 Eisai Business Overview
        11.20.3 Eisai Oncology Treatment Drug Introduction
        11.20.4 Eisai Revenue in Oncology Treatment Drug Business (2016-2021)
        11.20.5 Eisai Recent Development
    11.21 Merck KGaA
        11.21.1 Merck KGaA Company Details
        11.21.2 Merck KGaA Business Overview
        11.21.3 Merck KGaA Oncology Treatment Drug Introduction
        11.21.4 Merck KGaA Revenue in Oncology Treatment Drug Business (2016-2021)
        11.21.5 Merck KGaA Recent Development
    11.22 Gilead Sciences
        11.22.1 Gilead Sciences Company Details
        11.22.2 Gilead Sciences Business Overview
        11.22.3 Gilead Sciences Oncology Treatment Drug Introduction
        11.22.4 Gilead Sciences Revenue in Oncology Treatment Drug Business (2016-2021)
        11.22.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncology Treatment Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Immunotherapy (Biologic Therapy)
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Others
    Table 7. Global Oncology Treatment Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncology Treatment Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncology Treatment Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oncology Treatment Drug Market Share by Regions (2016-2021)
    Table 11. Global Oncology Treatment Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Oncology Treatment Drug Market Share by Regions (2022-2027)
    Table 13. Oncology Treatment Drug Market Trends
    Table 14. Oncology Treatment Drug Market Drivers
    Table 15. Oncology Treatment Drug Market Challenges
    Table 16. Oncology Treatment Drug Market Restraints
    Table 17. Global Oncology Treatment Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Oncology Treatment Drug Market Share by Players (2016-2021)
    Table 19. Global Top Oncology Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Treatment Drug as of 2020)
    Table 20. Ranking of Global Top Oncology Treatment Drug Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Oncology Treatment Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Treatment Drug Product Solution and Service
    Table 24. Date of Enter into Oncology Treatment Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Oncology Treatment Drug Revenue Market Share by Type (2016-2021)
    Table 28. Global Oncology Treatment Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Oncology Treatment Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Oncology Treatment Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Oncology Treatment Drug Revenue Market Share by Application (2016-2021)
    Table 32. Global Oncology Treatment Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Oncology Treatment Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Oncology Treatment Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Oncology Treatment Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Oncology Treatment Drug Product
    Table 67. Roche Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Celgene Company Details
    Table 70. Celgene Business Overview
    Table 71. Celgene Oncology Treatment Drug Product
    Table 72. Celgene Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 73. Celgene Recent Development
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Oncology Treatment Drug Product
    Table 77. Novartis Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 78. Novartis Recent Development
    Table 79. Bristol-Myers Squibb Company Details
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb Oncology Treatment Drug Product
    Table 82. Bristol-Myers Squibb Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Development
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Oncology Treatment Drug Product
    Table 87. Johnson & Johnson Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Merck & Co. Company Details
    Table 90. Merck & Co. Business Overview
    Table 91. Merck & Co. Oncology Treatment Drug Product
    Table 92. Merck & Co. Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 93. Merck & Co. Recent Development
    Table 94. AstraZeneca Company Details
    Table 95. AstraZeneca Business Overview
    Table 96. AstraZeneca Oncology Treatment Drug Product
    Table 97. AstraZeneca Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 98. AstraZeneca Recent Development
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 102. Pfizer Recent Development
    Table 103. Amgen Company Details
    Table 104. Amgen Business Overview
    Table 105. Amgen Oncology Treatment Drug Product
    Table 106. Amgen Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 107. Amgen Recent Development
    Table 108. Eli Lilly Company Details
    Table 109. Eli Lilly Business Overview
    Table 110. Eli Lilly Oncology Treatment Drug Product
    Table 111. Eli Lilly Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 112. Eli Lilly Recent Development
    Table 113. AbbVie Company Details
    Table 114. AbbVie Business Overview
    Table 115. AbbVie Oncology Treatment Drug Product
    Table 116. AbbVie Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 117. AbbVie Recent Development
    Table 118. Takeda Company Details
    Table 119. Takeda Business Overview
    Table 120. Takeda Oncology Treatment Drug Product
    Table 121. Takeda Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 122. Takeda Recent Development
    Table 123. Astellas Company Details
    Table 124. Astellas Business Overview
    Table 125. Astellas Oncology Treatment Drug Product
    Table 126. Astellas Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 127. Astellas Recent Development
    Table 128. Ipsen Company Details
    Table 129. Ipsen Business Overview
    Table 130. Ipsen Oncology Treatment Drug Product
    Table 131. Ipsen Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 132. Ipsen Recent Development
    Table 133. Sanofi Company Details
    Table 134. Sanofi Business Overview
    Table 135. Sanofi Oncology Treatment Drug Product
    Table 136. Sanofi Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 137. Sanofi Recent Development
    Table 138. Bayer Company Details
    Table 139. Bayer Business Overview
    Table 140. Bayer Oncology Treatment Drug Product
    Table 141. Bayer Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 142. Bayer Recent Development
    Table 143. Biogen Idec Company Details
    Table 144. Biogen Idec Business Overview
    Table 145. Biogen Idec Oncology Treatment Drug Product
    Table 146. Biogen Idec Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 147. Biogen Idec Recent Development
    Table 148. Teva Company Details
    Table 149. Teva Business Overview
    Table 150. Teva Oncology Treatment Drug Product
    Table 151. Teva Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 152. Teva Recent Development
    Table 153. Otsuka Company Details
    Table 154. Otsuka Business Overview
    Table 155. Otsuka Oncology Treatment Drug Product
    Table 156. Otsuka Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 157. Otsuka Recent Development
    Table 158. Eisai Company Details
    Table 159. Eisai Business Overview
    Table 160. Eisai Oncology Treatment Drug Product
    Table 161. Eisai Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 162. Eisai Recent Development
    Table 163. Merck KGaA Company Details
    Table 164. Merck KGaA Business Overview
    Table 165. Merck KGaA Oncology Treatment Drug Product
    Table 166. Merck KGaA Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 167. Merck KGaA Recent Development
    Table 168. Gilead Sciences Company Details
    Table 169. Gilead Sciences Business Overview
    Table 170. Gilead Sciences Oncology Treatment Drug Product
    Table 171. Gilead Sciences Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million)
    Table 172. Gilead Sciences Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Treatment Drug Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Features
    Figure 3. Targeted Therapy Features
    Figure 4. Immunotherapy (Biologic Therapy) Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Others Features
    Figure 7. Global Oncology Treatment Drug Market Share by Application: 2020 VS 2027
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Respiratory/Lung Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. Oncology Treatment Drug Report Years Considered
    Figure 15. Global Oncology Treatment Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Oncology Treatment Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Oncology Treatment Drug Market Share by Regions: 2020 VS 2027
    Figure 18. Global Oncology Treatment Drug Market Share by Regions (2022-2027)
    Figure 19. Global Oncology Treatment Drug Market Share by Players in 2020
    Figure 20. Global Top Oncology Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Treatment Drug as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oncology Treatment Drug Revenue in 2020
    Figure 22. Global Oncology Treatment Drug Revenue Market Share by Type (2016-2021)
    Figure 23. Global Oncology Treatment Drug Revenue Market Share by Type (2022-2027)
    Figure 24. North America Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Oncology Treatment Drug Market Share by Type (2016-2027)
    Figure 26. North America Oncology Treatment Drug Market Share by Application (2016-2027)
    Figure 27. North America Oncology Treatment Drug Market Share by Country (2016-2027)
    Figure 28. United States Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Oncology Treatment Drug Market Share by Type (2016-2027)
    Figure 32. Europe Oncology Treatment Drug Market Share by Application (2016-2027)
    Figure 33. Europe Oncology Treatment Drug Market Share by Country (2016-2027)
    Figure 34. Germany Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Oncology Treatment Drug Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Oncology Treatment Drug Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Oncology Treatment Drug Market Share by Region (2016-2027)
    Figure 44. China Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Oncology Treatment Drug Market Share by Type (2016-2027)
    Figure 52. Latin America Oncology Treatment Drug Market Share by Application (2016-2027)
    Figure 53. Latin America Oncology Treatment Drug Market Share by Country (2016-2027)
    Figure 54. Mexico Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Oncology Treatment Drug Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Oncology Treatment Drug Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Oncology Treatment Drug Market Share by Country (2016-2027)
    Figure 60. Turkey Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 68. Merck & Co. Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 69. AstraZeneca Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 71. Amgen Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 73. AbbVie Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 74. Takeda Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 75. Astellas Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 76. Ipsen Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 77. Sanofi Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 78. Bayer Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 79. Biogen Idec Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 80. Teva Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 81. Otsuka Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 82. Eisai Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 83. Merck KGaA Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Frequently Asked Questions
Oncology Treatment Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Treatment Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Treatment Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports